InterLeukin-7 (CYT107) to Improve Clinical Outcomes in Lymphopenic pAtients With COVID-19 Infection UK Cohort
Clinical trial NCT04379076 · TERMINATED
Trial details
- NCT number
- NCT04379076
- Sponsor
- Revimmune
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-05-14
- Primary completion
- 2022-02-28
- Enrollment
- 35
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.